東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/17 | 2,866 | 2,900 | 2,842 | 2,883 | +5 | +0.2% | 50,400 |
2022/01/14 | 2,900 | 2,908 | 2,848 | 2,878 | -49 | -1.7% | 79,700 |
2022/01/13 | 2,985 | 2,986 | 2,925 | 2,927 | -59 | -2% | 78,500 |
2022/01/12 | 2,941 | 3,005 | 2,941 | 2,986 | +61 | +2.1% | 80,300 |
2022/01/11 | 2,878 | 2,931 | 2,873 | 2,925 | +8 | +0.3% | 94,900 |
2022/01/07 | 2,927 | 2,934 | 2,883 | 2,917 | +24 | +0.8% | 57,500 |
2022/01/06 | 2,901 | 2,921 | 2,878 | 2,893 | -31 | -1.1% | 68,100 |
2022/01/05 | 2,968 | 3,015 | 2,897 | 2,924 | -14 | -0.5% | 169,100 |
2022/01/04 | 2,900 | 2,946 | 2,862 | 2,938 | +74 | +2.6% | 133,900 |
2021/12/30 | 2,842 | 2,884 | 2,841 | 2,864 | +27 | +1% | 124,400 |
2021/12/29 | 2,793 | 2,843 | 2,793 | 2,837 | +20 | +0.7% | 54,900 |
2021/12/28 | 2,756 | 2,817 | 2,734 | 2,817 | +81 | +3% | 64,400 |
2021/12/27 | 2,754 | 2,754 | 2,691 | 2,736 | -22 | -0.8% | 40,700 |
2021/12/24 | 2,760 | 2,772 | 2,733 | 2,758 | +34 | +1.2% | 92,600 |
2021/12/23 | 2,719 | 2,735 | 2,672 | 2,724 | +21 | +0.8% | 80,900 |
2021/12/22 | 2,724 | 2,731 | 2,674 | 2,703 | -1 | ±0% | 91,300 |
2021/12/21 | 2,730 | 2,742 | 2,695 | 2,704 | +24 | +0.9% | 120,600 |
2021/12/20 | 2,770 | 2,770 | 2,673 | 2,680 | -106 | -3.8% | 179,600 |
2021/12/17 | 2,810 | 2,824 | 2,780 | 2,786 | -22 | -0.8% | 119,600 |
2021/12/16 | 2,798 | 2,809 | 2,768 | 2,808 | +37 | +1.3% | 73,300 |
2021/12/15 | 2,727 | 2,777 | 2,727 | 2,771 | +8 | +0.3% | 51,800 |
2021/12/14 | 2,736 | 2,770 | 2,713 | 2,763 | +8 | +0.3% | 85,700 |
2021/12/13 | 2,767 | 2,779 | 2,727 | 2,755 | +38 | +1.4% | 91,000 |
2021/12/10 | 2,742 | 2,747 | 2,705 | 2,717 | -39 | -1.4% | 74,700 |
2021/12/09 | 2,816 | 2,818 | 2,737 | 2,756 | -75 | -2.6% | 78,600 |
2021/12/08 | 2,843 | 2,861 | 2,811 | 2,831 | +2 | +0.1% | 109,600 |
2021/12/07 | 2,736 | 2,838 | 2,728 | 2,829 | +131 | +4.9% | 114,700 |
2021/12/06 | 2,699 | 2,732 | 2,688 | 2,698 | +12 | +0.4% | 80,100 |
2021/12/03 | 2,623 | 2,689 | 2,623 | 2,686 | +58 | +2.2% | 77,600 |
2021/12/02 | 2,620 | 2,658 | 2,618 | 2,628 | -42 | -1.6% | 108,000 |
2021/12/01 | 2,619 | 2,690 | 2,619 | 2,670 | +44 | +1.7% | 163,600 |
2021/11/30 | 2,661 | 2,696 | 2,615 | 2,626 | -59 | -2.2% | 148,900 |
2021/11/29 | 2,743 | 2,743 | 2,678 | 2,685 | -99 | -3.6% | 105,000 |
2021/11/26 | 2,789 | 2,807 | 2,769 | 2,784 | -27 | -1% | 80,100 |
2021/11/25 | 2,802 | 2,825 | 2,791 | 2,811 | +21 | +0.8% | 55,400 |
2021/11/24 | 2,803 | 2,803 | 2,746 | 2,790 | -19 | -0.7% | 97,400 |
2021/11/22 | 2,754 | 2,831 | 2,754 | 2,809 | +55 | +2% | 98,500 |
2021/11/19 | 2,759 | 2,780 | 2,742 | 2,754 | -39 | -1.4% | 74,800 |
2021/11/18 | 2,811 | 2,831 | 2,781 | 2,793 | -20 | -0.7% | 81,400 |
2021/11/17 | 2,821 | 2,850 | 2,810 | 2,813 | -47 | -1.6% | 99,900 |
2021/11/16 | 2,973 | 2,975 | 2,852 | 2,860 | -89 | -3% | 131,100 |
2021/11/15 | 3,035 | 3,035 | 2,921 | 2,949 | -66 | -2.2% | 100,600 |
2021/11/12 | 2,992 | 3,030 | 2,986 | 3,015 | +52 | +1.8% | 76,400 |
2021/11/11 | 2,942 | 2,992 | 2,938 | 2,963 | +22 | +0.7% | 50,200 |
2021/11/10 | 2,941 | 2,957 | 2,901 | 2,941 | -3 | -0.1% | 113,600 |
2021/11/09 | 2,962 | 2,981 | 2,930 | 2,944 | -39 | -1.3% | 68,700 |
2021/11/08 | 2,964 | 2,987 | 2,954 | 2,983 | +49 | +1.7% | 91,900 |
2021/11/05 | 2,916 | 2,936 | 2,881 | 2,934 | +15 | +0.5% | 79,900 |
2021/11/04 | 2,942 | 2,949 | 2,895 | 2,919 | +11 | +0.4% | 126,400 |
2021/11/02 | 2,970 | 2,973 | 2,908 | 2,908 | -43 | -1.5% | 104,700 |
701~
750
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム